2Silverberg DS, Iaina A, Peer G, et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis [J]. Am J Kidney Dis, 1996, 27:234-238
3de Francisco AL, Fernandez FG, Rodrigo E, et al. Past,present and future of erythropoietin use in the elderly[J]. Iht Urol Nephrol, 2002, 33:187-193
4Kato A, Hamada M, Suzuki T, et al. Effect of weekly or successive iron supplementation on erythropoietin doses in patients receiving hemodialysis [J]. Nephron, 2001, 89:110-112
5Peacodk E, lindenfeld SM. Clinical practice guidelines for maintaining adequate iron status with intravenous iron dextran in hemodialysis patients [J]. ANNA J, 1999, 26:337-343
6Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation [J]. Am J Kidney Dis, 1995,26(1):41-46
7Dittrich E, Schillinger M, Sunder-Plassmann G, et al.Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients [J]. Perit Dial Int, 2002,22:60-66
8Silverberg DS, Blum M, Agbaria Z, et al. Intravenous iron for the treatment of predialysis anemia [J]. Kidney Int Suppl, 1999, 69:S79-S85
9Ahsan N. Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: a single center comparative study [J]. J Am Soc Nephrol, 1998, 9:664-668
10Sloand JA, Shelly MA, Erenstone AL, et al. Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies [J]. Perit Dial Int, 1998, 18:522-527
